Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Other events
  6. 8-K Event Shareholder vote results
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Executive or director change
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 8-K Event Material agreement · Regulation FD disclosure
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 8-K Event Executive or director change
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Shareholder vote results
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 1 of 4 · 72 filings